KOTYARK2024-10-012025-03-31KOTYARK2025-03-31KOTYARK2024-03-31KOTYARK2024-04-012025-03-31KOTYARK2024-10-012025-03-31in-capmkt:OtherExpenses1MemberKOTYARK2024-10-012025-03-31in-capmkt:OtherExpenses2MemberKOTYARK2024-04-012025-03-31in-capmkt:OtherExpenses1MemberKOTYARK2024-04-012025-03-31in-capmkt:OtherExpenses2MemberKOTYARK2024-10-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares000000KOTYARKNOTLISTEDINE0J0B01017KOTYARK INDUSTRIES LIMITEDSMEEquity2024-04-012025-03-312025-05-232025-05-15INRLakhsHalf YearlyYearlySingle segmentManufacturing of Bio Diesel2025-05-2316:05:002025-05-2318:30:00trueCash Flow IndirectDeclaration of unmodified opinion2024-10-012025-03-31AuditedConsolidated9134050003850000917255000823601000321451000-40127600025946000365980007691700079559000962796000-455410000-455410000-45541000-4975000-6356000-11331000-34210000000-3421000000-3421000010279100010-3.4-3.41.The consolidated financial results for the half year and year ended on March 31 2025 of Kotyark Industries Limited the Company or holding company and its subsidiaries holding company and subsidiaries together referred to as Group for the half year and year ended on March 31 2025 have been reviewed and recommended by the audit committee and approved by the Board of Directors at their respective meetings held on May 23 2025. The statutory auditors have carried out audit of the same and expressed an unmodified opinion. <BR> 2.The Consolidated financial results has been prepared in accordance with recognition and measurement principles laid down in the Accounting Standard as prescribed under section 133 of the Companies Act 2013 read with the Companies Accounting Standards Rules 2021 as amended from time to time and the provisions of the Companies Act 2013 as applicable and guidelines issued by the Securities and Exchange Board of India and other recognised accounting principles and policies generally accepted in India to the extent possible. The Financial Results of subsidiaries have been considered for consolidated financial results of the Group by combining like items of income and expenses and eliminating intragroup income and expenses.These Consolidated financial results are presented in accordance with the requirements of Regulation 33 of the SEBI LODR Regulations 2015 read with other relevant rules and circulars issued thereunder. <BR> 3. During the year the subsidiary company viz Kotyark Bio Specialities Limited has issued <BR> a)On January 07 2025 1190000 0.01 percent Unsecured Complusory Convertible Debenture of RS. 100 each for an aggregate consideration of Rs. 1190 lakhs under preferential basis through private placement. <BR> b) On January 16 2025 70,000 0.01 percent Unsecured Complusory Convertible Debenture of Rs. 100 each for an aggregate consideration of Rs. 70 lakhs under preferential basis through private placement. <BR> 4.The Group is engaged primarily in the business of manufacturing of bio-diesel and all its operation are in India only. Accordingly there is no separate reportable segment as per AS 17 on Segment Reporting in respect of the Group. <BR> 5.The Figures for the half year ended March 31 2024 and March 31 2025 are the balancing figures between audited figures in respect of year ended March 31 2024 and March 31 2025 and unaudited figures for the half year ended September 30 2023 and September 30 2024. <BR> 6.(i) The Board of Directors of Parent Company at its meeting held on October 29 2024 has declared an interim dividend of Rs.7.50 per equity share. <BR> (ii) The Board of Directors at its meeting held on May 23 2025 has proposed a final dividend of Rs.1.00 per equity share on face value of Rs.10 per equity share for the Financial Year 2024_25. This payment is subject to approval by shareholders in the ensuing Annual General Meeting of the Parent Company <BR> 7.Audited Statement of Assets and liabilities and Statement of Cash Flow are attached as Annexure A and Annexure B respectively. <BR> 8.Previous year’s or period's figures have been regrouped or reclassified wherever necessary. <BR> 2024-04-012025-03-31AuditedConsolidated2880983000750900028884920002324072000351825000-436250000470190007733100015257600016944500026860180002024740000202474000020247400065074000-6734000583400001441340000001441340000014413400010279100010013.9613.96Manufacturing Expenses29687000Operating and Other Expenses49872000Manufacturing Expenses63963000Operating and Other Expenses10548200010279100013277540000143054500000857000292702000000605000029875200039595200001229490001229490003704800063375000619324000234947800067183700000012914700008009840000215200000444720008476080000128311600096157000364500003319100085761000150187000023494780007527100015258700000000-98000-35300000224230000-437383000248217000-238100012294800011790000-1879000-5868800016554200036801600000058819000030919700000309197000000000009500000143907000000000098000000-13430900000-1343090000012600000001182450001541870007527100000-22170300000-221703000-468150000-46815000504600003645000AuditedtrueManubhai & Shah LLPtrue2028-02-29